Storia in 19 fonti

‘Breakthrough’ Moderna personalized mRNA cancer vaccine curbs melanoma reoccurrence

News of first positive large late-stage trial result for drug could signal new era for treating solid-tumor cancers, with tests underway for lung, breast and pancreatic cancers

Raccontata da

huffpost.com+7 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

timesofisrael.comStai leggendo1 g fa

‘Breakthrough’ Moderna personalized mRNA cancer vaccine curbs melanoma reoccurrence

News of first positive large late-stage trial result for drug could signal new era for treating solid-tumor cancers, with tests underway for lung, breast and pancreatic cancers

originale

Timeline cronologica

mercoledì 19 agosto 2026·biopharmadive.com
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna…
mercoledì 19 agosto 2026·timesofisrael.com
‘Breakthrough’ Moderna personalized mRNA cancer vaccine curbs melanoma reoccurrence
News of first positive large late-stage trial result for drug could signal new era for treating solid-tumor cancers, with tests underway for lung, breast and pancreatic cancers

‘Breakthrough’ Moderna personalized mRNA cancer vaccine curbs melanoma reoccurrence

Confronto fonti

‘Breakthrough’ Moderna personalized mRNA cancer vaccine curbs melanoma reoccurrence

Timeline cronologica

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

‘Breakthrough’ Moderna personalized mRNA cancer vaccine curbs melanoma reoccurrence

Moderna, Merck breakthrough could usher in a wave of cancer vaccines

New Cancer Treatment Hope After mRNA Vaccine Success

‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say

‘Breakthrough’ mRNA cancer drug curbs melanoma in large trial

Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?

A personalized mRNA therapy passes a phase 3 melanoma trial for the first time

Moderna y Merck anuncian el éxito de la primera vacuna personalizada contra el melanoma y sus acciones se disparan en Bolsa

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

Merck, Moderna say melanoma vaccine meets goals in large trial | CBC News

'Landmark moment' as vaccine stops cancer returning in striking trial

‘First time’: Drug giants’ cancer breakthrough

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks…

For Moderna, cancer vaccine results ease investor skepticism on its future as stock soars

Moderna and Merck shares soar on mRNA cancer vaccine

New Cancer Treatment Hope After mRNA Vaccine Success

Moderna y Merck anuncian el éxito de su vacuna contra el melanoma tras un ensayo con resultados prometedores

Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread

‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say

Health Care Up After Moderna Breakthrough — Health Care Roundup

Moderna shares nearly triple on skin cancer vaccine success

New Melanoma Vaccine Shows Promise In Fighting Cancer, Preventing Recurrence

Una vacuna contra el melanoma cerca de ser aprobada

Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?